Telesis Bio Inc SMA 50
Was ist das SMA 50 von Telesis Bio Inc?
SMA 50 von Telesis Bio Inc ist $4 -125.44%
Was ist die Definition von SMA 50?
SMA 50 ist ein durchschnittlicher Aktienkurs der letzten 50 Tage, berechnet als ungewichteter Mittelwert der 50 letzten Schlusskurse.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Telesis Bio Inc
Was macht Telesis Bio Inc?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Unternehmen mit sma 50 ähnlich Telesis Bio Inc
- Spark New Zealand hat SMA 50 von AUD$4 -22.93%
- Vikas EcoTech hat SMA 50 von ₨4 -4.76%
- Vikas EcoTech hat SMA 50 von ₨4 -4.20%
- Gold Reserve hat SMA 50 von $4 -4.34%
- Baytex hat SMA 50 von $4 +5.37%
- Leverage Sha Etp 2071 hat SMA 50 von €4 -0.80%
- Telesis Bio Inc hat SMA 50 von $4 -125.44%
- S.A.S. Dragon hat SMA 50 von HKD$4 +4.17%
- Kenmare Resources plc hat SMA 50 von €4 -1.54%
- Biosynex SA hat SMA 50 von €4 +10.20%
- Vanguard ETF Series - Vanguard S&P 500 Index ETF hat SMA 50 von $4 -0.10%
- Landore Resources hat SMA 50 von GBX4 -6.68%
- Antibe Therapeutics hat SMA 50 von CAD$4 -849.38%